D. Peake

发表

Guidelines for the management of soft tissue sarcomas . The British Sarcoma Group

I. Judson, R. Grimer, D. Peake, 2010 .

Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma

R. Grimer, D. Peake, L. Kindblom, 2011, Sarcoma.

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer

N. James, D. Stocken, D. Peake, 2004, British Journal of Cancer.

Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study

A. Darzi, R. Peto, P. Ziprin, 2020, The lancet. Gastroenterology & hepatology.

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

N. James, D. Peake, D. Wallace, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Soft-tissue sarcomas of the hand: oncological outcome and prognostic factors.

J. Thomas, R. Grimer, D. Peake, 2008, The Journal of bone and joint surgery. British volume.

A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting.

D. Rea, D. Peake, D. Palmer, 2008, Oncology reports.

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer

N. James, D. Stocken, D. Peake, 2004, British Journal of Cancer.

Treatment of gastric cancer.

D. Peake, J. Fielding, 2006, The New England journal of medicine.

Non‐fibrosing sclerosing epithelioid fibrosarcoma: an unusual variant

F. Mertens, D. Peake, L. Magnusson, 2016, Histopathology.

Paget's Osteosarcoma — no Cure in Sight

R. Grimer, D. Peake, R. Tillman, 1999, Sarcoma.

UK Guidelines for the Management of Bone Sarcomas

I. Lewis, B. Morland, I. Judson, 2010, Sarcoma.

Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.

R. Grimer, D. Peake, R. Tillman, 2016, The bone & joint journal.

Does the method of treatment affect the outcome in soft-tissue sarcomas of the adductor compartment?

F. Sim, J. Wunder, B. O'Sullivan, 2006, The Journal of bone and joint surgery. British volume.

Gastrointestinal stromal tumour with a KIT exon 11 mutation presenting as a paratesticular mass.

D. Peake, J. Meis, S. Hilman, 2009, The British journal of radiology.

Use of imatinib mesylate in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network experience.

D. Peake, P. Tanière, D. Spooner, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

UK Guidelines for the Management of Bone Sarcomas

I. Lewis, B. Morland, I. Judson, 2010, Sarcoma.

UKGuidelines for theManagement of Bone Sarcomas

I. Lewis, I. Judson, R. Grimer, 2010 .

The 'other' bone sarcomas: prognostic factors and outcomes of spindle cell sarcomas of bone.

R. Grimer, D. Peake, E. Pakos, 2011, The Journal of bone and joint surgery. British volume.

Vortex Trial: A Randomized Controlled Multicenter Phase 3 Trial of Volume of Postoperative Radiation Therapy Given to Adult Patients With Extremity Soft Tissue Sarcoma (STS).

A. Davis, L. Billingham, R. Grimer, 2016 .

Radiotherapy for the Palliation of Advanced Sarcomas—The Effectiveness of Radiotherapy in Providing Symptomatic Improvement for Advanced Sarcomas in a Single Centre Cohort

D. Peake, J. Sherriff, D. Spooner, 2019, Healthcare.

Common acute oncological emergencies: diagnosis, investigation and management

D. Peake, A. Chan, N. Walji, 2008, Postgraduate Medical Journal.

Guidelines Guidelines for the Management of Soft Tissue Sarcomas

I. Judson, R. Grimer, D. Peake, 2014 .

Guidelines Guidelines for theManagement of Soft Tissue Sarcomas

I. Judson, R. Grimer, D. Peake, 2010 .

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.

J Raftery, F Song, J. Raftery, 2005, Health technology assessment.

Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision

A. Darzi, R. Peto, P. Ziprin, 2022, The Lancet. Healthy longevity.

Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial

Jacob G. Scott, H. J. Pearson, C. Fuller, 2012 .

Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma?

D. Peake, R. Tillman, S. Carter, 2011, The Journal of bone and joint surgery. British volume.

ONCOLOGICAL OUTCOME AND PROGNOSTIC FACTORS

J. Thomas, R. Grimer, D. Peake, 2008 .

Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma

U. Dirksen, R. Randall, D. Peake, 2020, Clinical sarcoma research.

Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults

D. Peake, T. Shimabukuro, J. Baggs, 2022, Vaccine.

UK guidelines for the management of bone sarcomas

B. Morland, I. Judson, D. Peake, 2016, Clinical Sarcoma Research.

Guidelines for the Management of Soft Tissue Sarcomas

I. Judson, R. Grimer, D. Peake, 2010, Sarcoma.

Common acute oncological emergencies: diagnosis, investigation and management

D. Peake, A. Chan, N. Walji, 2008, Postgraduate Medical Journal.

Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.

R. Grimer, D. Peake, R. Tillman, 2016, The bone & joint journal.